BRIEF published on 02/13/2025 at 22:00, 9 months 19 days ago Integrated BioPharma Reports Quarterly Results with Increased Revenue Revenue Growth Q4 Results Operating Income Customer Base Expansion Integrated BioPharma
PRESS RELEASE published on 02/13/2025 at 21:55, 9 months 19 days ago Integrated BioPharma Reports Results for its Quarter Ended December 31, 2024 Integrated BioPharma, Inc. reports 9.6% increase in revenue to $12.6 million for quarter ended Dec 31, 2024. Operating income of $0.2 million. Detailed financial results provided Financial Results Revenue Increase Quarterly Report Operating Income Integrated BioPharma
BRIEF published on 11/13/2024 at 23:38, 1 year ago Integrated BioPharma, Inc. annonce ses résultats financiers du troisième trimestre 2024 Croissance Des Revenus Revenu Net Résultats Du 3ème Trimestre 2024 Biopharmacie Intégrée Diversification De La Clientèle
BRIEF published on 11/13/2024 at 23:38, 1 year ago Integrated BioPharma, Inc. Announces Q3 2024 Financial Results Revenue Growth Net Income Integrated BioPharma Customer Diversification Q3 2024 Results
PRESS RELEASE published on 11/13/2024 at 23:33, 1 year ago Integrated BioPharma Reports Results for its Quarter Ended September 30, 2024 Integrated BioPharma, Inc. reports revenue growth in Q3 2024 with net income of $0.3 million. Diversification of customer base leads to increased financial performance Revenue Growth Financial Performance Diversification Q3 2024 Integrated BioPharma
BRIEF published on 09/20/2024 at 23:45, 1 year 2 months ago Integrated BioPharma annonce ses résultats financiers pour le trimestre et l'exercice clos le 30 juin 2024 Résultats Financiers Résultat D'exploitation Revenu Net Revenu Biopharmacie Intégrée
BRIEF published on 09/20/2024 at 23:45, 1 year 2 months ago Integrated BioPharma Announces Financial Results for Quarter and Fiscal Year Ended June 30, 2024 Financial Results Revenue Net Income Operating Income Integrated BioPharma
PRESS RELEASE published on 09/20/2024 at 23:40, 1 year 2 months ago Integrated BioPharma Reports Results for Its Quarter and Fiscal Year Ended June 30, 2024 Integrated BioPharma, Inc. reports financial results with minor revenue decrease. Emphasis on core businesses for growth and diversification of customer base Financial Results Revenue Decrease Customer Base Integrated BioPharma Core Businesses
BRIEF published on 05/10/2024 at 22:35, 1 year 6 months ago Integrated BioPharma publie ses résultats financiers pour le premier trimestre 2024 Résultats Financiers Rapport Trimestriel Résultat D'exploitation Stabilité Des Revenus BioPharma Intégrée
BRIEF published on 05/10/2024 at 22:35, 1 year 6 months ago Integrated BioPharma Releases Financial Results for Q1 2024 Financial Results Quarterly Report Operating Income Revenue Stability Integrated BioPharma
Published on 12/05/2025 at 02:35, 4 hours 53 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 6 hours 28 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 23 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 28 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 07:00, 28 minutes ago Swiss Re targets a net income of USD 4.5 billion in 2026; refreshed strategy to strengthen core business
Published on 12/05/2025 at 03:30, 3 hours 58 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 37 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 11 hours 3 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 11 hours 13 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 18:14, 13 hours 13 minutes ago Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 13 hours 28 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
Published on 12/04/2025 at 18:00, 13 hours 28 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 43 minutes ago Informations relatives au nombre total de droits de vote et d’actions
Published on 12/04/2025 at 17:45, 13 hours 43 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
